Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Asset Utilization Ratio (2016 - 2025)

Editas Medicine (EDIT) has disclosed Asset Utilization Ratio for 10 consecutive years, with 0.22 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 29.75% to 0.22 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.22, a 29.75% increase, with the full-year FY2024 number at 0.08, down 50.14% from a year prior.
  • Asset Utilization Ratio was 0.22 for Q3 2025 at Editas Medicine, up from 0.16 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.22 in Q3 2025 to a low of 0.03 in Q3 2021.
  • A 5-year average of 0.1 and a median of 0.1 in 2024 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: crashed 77.26% in 2021, then skyrocketed 323.12% in 2024.
  • Editas Medicine's Asset Utilization Ratio stood at 0.04 in 2021, then grew by 2.94% to 0.04 in 2022, then soared by 312.75% to 0.16 in 2023, then crashed by 37.95% to 0.1 in 2024, then surged by 132.95% to 0.22 in 2025.
  • Per Business Quant, the three most recent readings for EDIT's Asset Utilization Ratio are 0.22 (Q3 2025), 0.16 (Q2 2025), and 0.12 (Q1 2025).